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Summary 
This report  examines the adhesive interactions  of human  CD4 + T  lymphocytes with  tumor 
necrosis factor a-activated human endothelial cell monolayers in an in vitro model that mimics 
microcirculatory flow conditions. Resting CD4 + T cell interactions with activated endothelium 
consisted of initial attachment followed by rolling,  stable arrest,  and then spreading and trans- 
endothelial migration. P-selectin, but not E-, or L-selectin, mediated most of this initial contact 
and  rolling,  whereas  Brintegrins  (ot4fll),  interacting  with  endothelial-expressed  vascular cell 
adhesion molecule 1, participated in rolling and mediated stable arrest.  In contrast, fl2-integrins 
were primarily involved in spreading and transmigration.  These findings highlight an important 
role for P-selectin and suggest discrete functions for fir  and fl2-integrins  during lymphocyte 
recruitment  to  sites  of immune-mediated  inflammation. 
p eripheral blood CD4 + lymphocyte adhesive  interactions 
with vascular endothelium are essential for normal im- 
mune function and for recruitment to sites of inflammation. 
Previous in vitro studies (1-4) have demonstrated that T cell 
adhesion to cultured endothelial cells under static conditions 
is mediated by multiple adhesion pathways and is dependent 
on  the  state  of activation  of both  cell  types.  For resting 
CD4 + cell adhesion  to  activated endothelial  cells,  at least 
three separate receptor-ligand pairs are involved: intercellular 
adhesion  molecule 1 (ICAM-1)-LFA-1;  vascular cell adhe- 
sion molecule  1 (VCAM-1)l-very late antigen  4  (VLA-4) 
(r  E-selectin-sialyl Lewis  x, and/or related  carbohydrates 
on leukocytes. Recent studies in vivo or in vitro under flow 
conditions have revealed  that multiple receptor-ligand pairs 
can act sequentially and in an overlapping manner to effect 
leukocyte initial attachment,  rolling,  stable arrest,  and ulti- 
mately, emigration (4). Current models propose that members 
of the selectin gene family (E-, P-, and L-selectin) mediate 
the initial adhesive interactions,  termed leukocyte "rolling" 
(4-11) or "tethering" (12) and that subsequent firm adhesion 
and diapedesis requires activation-dependent engagement of 
integrins with their endothelial ligands, and CD31 (platelet/ 
endothelial cell adhesion molecule 1 [PECAM-1]) (13), respec- 
tively. These models are based on observations with neutro- 
phils and monocytes, and the extent to which lymphocytes 
1 Abbreviations used in this paper'. HEC, human umbilical vein endothelial 
cell; VCAM-1, vascular cell adhesion molecule 1. 
follow this paradigm remains untested. Using an in vitro flow 
chamber to simulate flow conditions likely to exist in post- 
capillary venules (14) and function-blocking mAbs, we studied 
the cellular processes and molecular events involved in CD4 + 
T  cell adhesion to TNF-a-activated  human umbilical vein 
endothelial  cell  (HEC) monolayers. 
Materials  and Methods 
Endothelial  Cell  Cultures,  CD4 +  T  Lymphocytes,  and Murine- 
transfected Cell Lines.  HECs were isolated and cultured as previ- 
ously described (15). Confluent HEC monolayers were treated with 
or without TNF-ce (recombinant human,  50 ng/ml; Genentech, 
Inc., San Francisco, CA) in M199-10% FCS for 6 h at 37~  before 
immunofluorescence  staining  or flow chamber  studies. Chinese 
hamster ovary (CHO) cells expressing a stably transfected human 
P-selectin cDNA (CHO P-sdectin) were obtained from Dale Cure- 
ruing (Genetics Institute,  Cambridge,  MA). L-cells expressing a 
stably transfected human E-sdectin cDNA or a seven-domain form 
of human VCAM-1 cDNA were obtained from Thomas E Tedder 
(Duke University, Durham,  NC). Transfected L ceils were cultured 
in DMEM containing 10% FCS, antibiotics, t-glutamine, and min- 
imal essential amino acids (5). CD4 + T cells were purified from 
single donor human platelet pheresis residues by sequential density 
gradient centrifugation  and elutriation,  followed by culture over- 
night and then positive selection on Dynabeads (model M-450 CD4) 
and DETACHaBEAD  (Dynal,  Great  Neck,  NY). 
mAb  Reagents.  Function  blocking  anti-L-selectin antibodies 
LAM1-3 and LAM1-4, and nonblocking  anti-L-sdectin antibody 
LAM1-14 (all IgG1) were  obtained  from Thomas  Tedder (16). 
Blocking anti-bselectin  antibody Dreg-56 was obtained from Eu- 
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b-selectin antibodies were used as purified IgG at 10/zg/ml. Block- 
ing and nonblocking anti-P-selectin antibodies, HDPG 2/3 and 
HPDG2/1 (both IgG1), respectively,  were obtained  from Dale Cum- 
mings (17) and were used as purified IgG at 10/~g/ml. Blocking 
and nonblocking  anti-VCAM-1 antibodies  E1/6 and Hu8/4 (IgG1), 
respectively, were used as purified IgG at 20/zg/ml (18). Blocking 
anti-E-selectin antibodies H18/7 (19) and 7A9, the latter obtained 
from Walter  Newman (Lukosite,  Boston, MA), were used as purified 
IgG or F(ab')2 fragments at 25/zg/ml. Blocking anti-cc4-integrin 
(CD49d) antibody HP2.1 (Amac, Inc., Westbrook, ME) was used 
as purified IgG at 25 #g/ml. Function-blocking anti-Bz-integrin 
TS1/18, clone #HB203 (American  Type Culture Collection, Rock- 
ville, MD) was used as purified IgG at 20 #g/ml. Murine mAb 
K16/16 (IgG1) was used as an isotype-matched, nonbinding con- 
trol. For adhesion  assays  under flow, HECs were treated with mAb 
for 30 min at 37~  and T cells were incubated for 15 min at 4~ 
for 15 min before use in assays. All mAbs were used at saturating 
concentrations as determined by indirect immunofluorescence  flow 
cytometry. 
Immunofluorescent  Staining and Analysis of Cells.  Untreated and 
TNF-treated HECs, and CHO-P-selectin  cells  were  harvested  nonen- 
zymatically from the culture plates using HBSS containing 3 mM 
EDTA (15 min at 37~  5% COs) and stained with HPDG2/3 
anti-P-selectin mAb  followed by FITC-conjugated goat F(ab')2 
anti-mouse  Ig (1:30 dilution;  Caltag, San Francisco, CA) (5). 
Purified T cells were stained with phycoethrin (PE)-labeled anti- 
CD4 and fluorescein  isothiocyanate (FITC)-labeled anti-CD8, or 
PE-labeled anti-CD4 and FITC-labeled  anti-CD3 (Caltag). T cells 
were also stained with anti-L-selectin (LAM1-3) as detailed (5). 
Single- and two-color cell fluorescence  of 10,000 cells was deter- 
mined by flow cytometry on a FACScan  |  (Becton Dickinson & 
Co., Mountain View, CA). 100% of the cells in each staining tube 
were gated. 
Parallel  Plate Flow Chamber  Analysis of  Endothelial-Lymphocyte  In- 
teractions.  The flow chamber apparatus used in these studies has 
been described in detail (5, 20). Briefly, the chamber consists of 
two stainless steel plates separated by a silastic gasket. The flow 
field  dimensions  are 5 mm wide x 30 mm long x 0.250 mm high. 
Confluent endothelial cells, or CHO-P-selectin, L cell E-selectin 
or L cell VCAM-1 monolayers grown to '~90% of confluence on 
circular 25-mm glass coverslips (Fisher Scientific, Inc., Medford, 
MA) were placed in the flow chamber. Defined flow levels were 
applied by drawing media containing T cells (106/ml) through the 
chamber using a syringe pump (model 44; Harvard Apparatus Inc., 
Natick, MA). Temperature  was maintained  at 37  ~ by heating plates. 
The flow apparatus was mounted on an inverted  microscope  (Nikon 
Diaphot) and the entire perfusion period (10 min for each condi- 
tion) was recorded on videotape by a video camera and VCR. Leu- 
kocyte  adhesion  was determined  as previously  detailed  (5) and rolling 
velocities were determined using an automated PC-based image 
analysis software program (OPTIMAS; Bioscan, Inc., Edmonds, 
WA). Each antibody used was also included at saturating levels 
in the perfusion buffer. 
Results and Discussion 
TNF-c~ treatment of HECs induces expression of E-selectin 
and upregulated expression  of VCAM-1  and ICAM-1  (4, 
18, 19). TNF treatment also induced surface expression  of 
P-selectin  that was increased at 6 h and declined to baseline 
after 24 h  as detected by indirect immunofluorescence and 
flow cytometry  with anti-P-selectin mAb (HPDG 2/3) (Fig. 
1 A). Control secondary FITC-labeled IgG is shown for com- 
parison and was identical to an isotype-matched K16/16 (IgG1) 
nonbinding control (for clarity, data not shown). In addi- 
tion,  CHO-P-selectin  cells  uniformly expressed  levels of 
P-selectin (Fig. 1 B) that were similar to activated HECs (com- 
pare Fig. 1, A to B). CHO-P-selectin cells did not react with 
mAb directed to E-selectin (H18/7 or 7A9) or control isotype- 
matched nonbinding K16/16 (not shown). Similarly,  mu- 
rine L cells stably transfected with human E-selectin (L cell 
E-selectin) or VCAM-1 (L cell VCAM-1) uniformly expressed 
E-selectin or VCAM-1, respectively, at levels that were similar 
to those of 6-h, TNF-ot-activated HECs (not shown), but 
did not react with anti-P-selectin, -E-selectin mAbs or isotype- 
matched nonbinding mAb K16/16. 
Purified CD4 + T cells were 98  _  2% positive for both 
CD3 and CD4 (n  =  14), and >--75% of cells expressed high 
levels of  L-selectin (Fig. 2, A-C). These purified T cells were 
69  _+  16%  CD45RO + and 23  +  14%  CD45RA + and 
<1% of purified cells were class II MHC positive as deter- 
mined by immunofluorescence flow cytometry. In addition, 
purified cells could be stimulated to incorporate [3H]thymi- 
dine and secrete IL-2 (as determined by the HT-2 bioassay) 
by incubation with PHA (10 #g/ml) or plate-bound anti- 
CD3 (OKT3) in the presence of irradiated blood mononuclear 
cell  from the same  donor.  Unstimulated cells  showed no 
significant proliferative  or cytokine secretory activity. 
CD4 +  T  cell  adhesive  interactions with  6-h  TNF-ot- 
activated HECs were examined under defined laminar flow 
using a previously described in vitro flow model (5).  Sub- 
stantial CD4 + T cell rolling and stable adhesion (arrest) oc- 
curred at 1.8 dynes/cm2; at a higher level of flow (4.4 dynes/ 
cm2), few, if any, rolling or arrested  cells were observed.  In 
contrast, unactivated HEC monolayers did not support rolling 
interactions  or  arrest  of CD4 +  T  cells  at  or  above  1.8 
dynes/cm  2. 
Visual examination of CD4 § T cell interactions with the 
activated  HECs revealed numerous T  cells in contact with 
the apical surface of the endothelium. The initial contact con- 
sisted of freely flowing T  cells abruptly coming to a com- 
plete halt on an endothelial cell surface. This contact was similar 
to that previously detailed for monocyte interactions with 
IL-4-activated HECs (5). Typically, each high-powered (x 40) 
field contained ,,o20 T cells of which one third (36  -  6%) 
were rolling while the remaining cells were stably adhered. 
In these studies,  arrested CD4 + T  cells either:  (a)  subse- 
quently began slowly rolling downstream on the apical sur- 
faces of endothelial cells at 3.8 _+ 0.5/~mA (Table 1) for vari- 
able periods of time before stably arresting or releasing  to 
the flow stream;  (b)  remained adherent and retained their 
round, spherical shape; (c) remained stably adherent for sev- 
eral minutes and then spread on the apical surface; (d) spread 
on the apical endothelial surface and migrated to intercel- 
lular borders before transmigrating beneath the monolayers; 
or (e) released to the flow stream. The video images in Fig. 
3 depict the sequence of cellular events that leads to T cell 
transmigration across 6oh TNF-activated endothelial mono- 
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Figure  1.  Surface  expression of P-selectin on TNF-ct-activated HEC 
and CHO cell monolayers. TNF-~-activated HEC monolayers (.4) and 
CHO P-selectin cells (B) were analyzed for P-sdectin expression  by im- 
munofluorescence  and flow cytometry. Anti-P-sdectin staining is shown 
by the heavy tracings and background staining by secondary  FITC-labeled 
antibody is shown by the light tracings. 
layers under laminar  flow at  1.8 dynes/cm  2.  In Fig.  3 a,  a 
stably arrested T  cell (a,  arrow) begins to spread (b) before 
transmigrating  beneath  the  endothelial  monolayer  (c-e). 
CD4 + T  cell diapedesis usually occurred rapidly (minutes) 
once T  cells had been stably arrested on the apical surface 
for several minutes. In addition, two rolling lymphocytes (ar- 
rowheads) enter the field from the right (Fig. 3, b and c, respec- 
tively) and roll across the monolayer (flow is from right to 
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Figure 2.  Phenotype of purified CD4 + T cells. T cells were stained 
with PE-labeled  anti-CD4 and FITC-labeled  anti-CD8 (A), or PE-labeled 
anti-CD4 and FITC-labeled  anti-CD3 (/3). T cells were also stained with 
anti-L-selectin  (heavy tracing) or isotype  matched  control mAb (light tracing), 
followed by FITC-anti mouse Ig (C). 
Table  1.  CD4 + T  Cell Rolling  Velocities  on  TNF-activated 
HEC 
CD4 § T  cell 
mAb treatments  rolling velocities 
~m/s 
Media  3.8  _+ 0.5 
L-selectin  (LAM1-14, control mAb)  4.3  +  0.6 
L-selectin  (LAM1-3 mAb)  4.8  +  1.1 
P-selectin  (HPDG2/1,  control mAb)  3.9  _+  1.4 
P-selectin  (HDPG 2/3  mAb)  6.1  +  1.3 
E-selectin  (H18/7 mAb)  3.6  _+  1.7 
VCAM-1  (Hu8/4,  control mAb)  3.9  +  0.6 
VCAM-1  (E1/6 mAb)  8.0  -+  0.8* 
ot4/3t-integrins (HP2.1 mAb)  5.9  _+ 0.6* 
~82-integrins (TS1/18 mAb)  3.8  +  0.7 
ot4•1-  and/82-integrins (HP2.1 and TS1/18)  6.8  +  1.1" 
The velocities of CD4 §  T  cells rolling  on  TNF-o~-activated HEC 
monolayers was determined at four separate time points after 9-10 min 
of perfusion by measurement of the distance CD4+ T cells traveled in 
60 consecutive frames of videotape using an automated PC-based image 
analysis software program (OPTIMAS, Bioscan, Inc., Edmonds, WA). 
Data are mean _+ SEM; 20--40 individual cells for each mAb treatment 
were analyzed in two to three separate experiments. 
*p ~0.009 versus media, or control mAb LAMI-14 and Hu8/4. 
left).  The lymphocyte entering in c, which is lower in the 
field, rolls at a higher velocity than the lymphocyte that enters 
in  b.  Observation  under  a  x40 objective clearly indicated 
that CD4 § T  cells were rolling and not sliding or tumbling; 
the large nucleus rotated as the cell traveled across the HEC 
surface. The patterns of several selected CD4 + T  cells rolling 
on activated HECs are shown in Fig. 4 and demonstrate the 
variable behavior of rolling T  cells. Certain T  cells rolled at 
steady velocities, either fast or slow, while others rolled for 
a few seconds before stably arresting  again  or releasing to 
the flow stream. This behavior was consistently observed in 
this  system  in  several  separate  experiments.  Others  have 
reported similar behavior for lyrnphocytes interacting with 
endothelium in high endothelial venules (HEV) in situ (21, 22). 
We next investigated the mechanisms that mediated these 
adhesive interactions  using  function blocking  mAb  under 
flow at  1.8 dynes/cm  2. Inhibition of L-selectin by function 
blocking mAb (LAM1-3) did not reduce the number of ad- 
herent CD4 + T  cells adhesion  (Fig.  5) or their rolling ve- 
locities (Table 1). Other blocking mAb to L-selectin (LAM1-4, 
DREG-56) also had no inhibitory effect (not shown). Con- 
trol nonblocking isotype-matched mAb directed to L-selectin 
(LAM1-14) had no effect. In addition, PMA stimulation (100 
ng/ml,  15 rain at 37~  of CD4 + T  cells did not alter their 
adhesion to TNF-activated HEC monolayers (unactivated T 
cells,  357  +  168 cells/ram 2 versus PMA-activated,  359  + 
125 cells) even though this treatment caused near total loss 
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Figure  4.  Behavior of rolling CD4 * cells during interactions with 6-h 
TNF-a-activated  HEC  monolayers  under  flow  at  1.8  dynes/cm  z.  The 
traces of selected CD4 §  T  cells illustrate their variable rolling behavior 
on HEC under flow.  In particular, one cell (solid t~ngle)  rolls at '~8 #m/s 
for 6  s before releasing to the flow  stream (OFF). 
of L-selectin expression. Treatment with anti-E-selectin mAb 
H18/7 reduced adhesion in two of nine separate experiments, 
however, overall H18/7 did not significantly reduce adhesion. 
Another  function-blocking  mAb to E-selectin (mAb 7A9) 
also did not reduce adhesion (data not shown) in two experi- 
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Figure  3.  CD4 *  T  cells  roll 
on TNF-ol-activated HEC mono- 
layers  under  flow.  Confluent 
TNF-~ activated (6 h, 50 ng/ml) 
monohyers were inserted into the 
flow chamber and CD4 + T  cells 
were perfused across  the mono- 
layer at  1.8 dynes/cm  2 (0.9 ml/ 
rain)  as  previously  detailed  (5). 
Flow is from right to left. Digi- 
tized video  images  of CD4 +  T 
cells rolling on HEC monolayers 
were obtained 14, 23, 5, and 10 s 
apart (x 40). The arrow indicates 
a cell that arrests (a), spreads (b), 
and then transmigrates (c-e). Two 
lymphocytes  rolling  at  different 
velocities are indicated by arrow- 
heads  (b-e). 
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Figure  5.  Monodonal inhibition of CD4 + T  cell adhesion on TNF- 
a-activated HEC monolayers. Confluent TNF-c~-activated (6 h, 50 ng/ml) 
or control HEC monolayers were washed three times, incubated with in- 
dicated mAb at saturating concentrations (see Materials and Methods) for 
30  rain at  37~  and  inserted into  the flow  chamber.  Concomitantly, 
CD4 +  cells  were  incubated with  appropriate  mAb for  15  min  on ice, 
diluted to 12 ml and perfused across monolayers at 1.8 dynes/cm  2. Firmly 
adherent cells were determined (12-15  fields at  x40) after 9-10 min of 
perfusion (rolling cells were not included). N  =  five to nine separate ex- 
periments for each mAb treatment; unactivated, N  =  15 and TNF-a  + 
media,  N  =  15.  *p g0.025  by paired Student's t  test. 
1182  CD4 §  T  Lymphocyte  Adhesion to Endothelium under  Flow ments. Thus, in one experiment where H18/7 reduced adhe- 
sion on activated HECs,  several CD4 + cells per field en- 
gaged in rolling interactions with L cell E-selectin monolayers, 
whereas in  three other experiments in which H18/7  had 
no effect, few, if any CD4 + T  cells interacted with L cell 
E-selectin monolayers. Although previous studies have shown 
that T  cells bind to E-selectin (1, 23,  24), this population 
of lymphocytes appears  to constitute a subset of circulating 
memory T  cells (referred to as "skin homing" [24]) which 
varies with each blood donor, and, therefore, may have been 
too small to detect in all T  cell preparations in our assay. 
In contrast, anti-P-selectin mAb (HPDG 2/3) reduced ini- 
tial attachment of T cells and thus reduced adhesion by 50% 
(p g0.007; n  =  8). A control isotype-matched nonblocking 
anti-P-selectin mAb HPDG 2/1 had no significant effect on 
adhesion (389  +  103, n  =  2) or rolling velocities (Table 1). 
Although inhibition of P-selectin by mAb HPDG 2/3 in- 
creased rolling velocities (Table  1),  the difference was not 
significant (p ;>0.13). This is not surprising since the initial 
attachment and thus adhesion of up to 50% of T  cells was 
independent of P-selectin and the rolling velocities of these 
cells were averaged into the determination. This result sug- 
gests that the P-selectin mAb inhibition was incomplete or 
that other adhesion molecule(s) are operative in this system. 
The combination of anti-P-selectin with blocking L-selectin 
mAb was not more effective than anti-P-selectin mAb alone 
(',o50% inhibition; p ~0.025, n =  2). Furthermore, the com- 
bination of mAb directed to E-, L-, and P-selectin was not 
more effective than P-selectin alone. As further evidence for 
P-selectin involvement, we examined CD4 + T  cell interac- 
tions with CHO-P-selectin monolayers (Fig.  6). The pho- 
tomicrographs in Fig. 6 depict the movements of five different 
CD4 + T cells on CHO-P-selectin monolayers treated with 
control mAb H18/7  (nonbinding).  Three CD4 +  T  cells 
were rolling along the apical  surface at different velocities 
(arrows, Subtracted  Image), while two other T cells remained 
stationary (arrowheads).  The average rolling velocity of 40 cells 
rolling on CHO-P-selectin was 38 _+ 18 #m/s (mean +  SD, 
n  -- 3 experiments). In general, T cells interactions consisted 
of cells rolling and transiently adhering for a few seconds 
before rolling again. No stably adherent cells (adherent for 
>10 s) were observed, mAb HPDG 2/3 mAb totally abol- 
ished CD4 §  T  cell interactions, whereas control K16/16, 
anti-E-selectin (mAb H18/7) and nonblocking HPDG 2/1 
had no effect. We note here that both CHO-P-selectin and 
L cell E-selectin monolayers supported both human mono- 
cyte and neutrophil rolling at  1.8  dynes/cm2; appropriate 
function blocking mAb totally abolished leukocyte rolling 
(our unpublished observations). 
O~431 integrins  interacting  with  endothelial-expressed 
VCAM-1 was the predominant mechanism that mediated ar- 
rest of rolling CD4 + T cells, whereas 32-integrins were in- 
volved in spreading and  transmigration under flow.  mAb 
directed to either O/481 (HP2.1  mAb) or VCAM-1  (E1/6) 
blocked 61 and 75% of adhesion (Fig.  5), respectively,  and 
both mAbs significantly increased the rolling velocities (Table 
1). Inhibition of this pathway resulted in an increase in both 
the number of rolling cells, since T cells were unable to stably 
arrest, and their rolling velocities (Table 1). These data sug- 
gest that rolling is mediated through overlapping functions 
of P-selectin and VCAM-ot4~I pathways under flow.  The 
ability of VCAM-ot4fll pathway alone to mediate arrest or 
support rolling under flow was further examined using L cell 
VCAM-1  monolayers.  At  1.8  dynes/cm  2,  CD4 +  T  cell 
rolling on VCAM-1 L cell monolayers was an extremely rare 
event characterized by a transient tumbling motion of the 
T cells followed by release. Stable arrest (~>10 s) was not ob- 
served. Thus, o_~_//1-VCAM-1 interactions were not sufficient 
to mediate rolling or arrest of unactivated CD4 § T cells at 
1.8 dynes/cm  2 in this system. In contrast, anti-B2-integrin 
mAb (TS1/18) did not significantly alter adhesion or rolling 
velocities.  However, mAb to B2-integrins reduced lympho- 
cyte spreading and/or transmigration across activated HECs 
by 53%  (15  _+  6% cells spread/transmigrated, p  ~<0.0002, 
n  =  2) as compared with anti-oe4fll or nonblocking anti-L- 
selectin (LAM1-14) mAb (39  _+  11 and 32  +  10%, respec- 
tively). Furthermore, when both 81" and 32-integrins were 
simultaneously blocked with mAbs, nearly all T cells were 
rolling and few T  cells arrested (25  _+  25 cells/ram2), and 
the rolling velocities were increased significantly as compared 
with control treatments (Table  1). This is consistent with 
in vivo studies suggesting involvement of both 81- and 32- 
integrins in peripheral T cell recruitment to sites of immune 
reactions (25). 
Several features of our analyses of CD4 § T  cell interac- 
tions with endothelial monolayers under flow merit emphasis. 
First, almost 40% of CD4 + T cells in contact with the ac- 
tivated endothelial monolayer rolled on TNF-c~-activated en- 
dothelium under flow.  The rolling velocities of CD4 + T 
cells were about twofold less than that reported for neutro- 
phils rolling on TNF-c~-activated HEC under flow at 1.85 
dynes/era  2 (10). Interestingly, the pattern of adhesion of the 
lymphocytes to TNF-activated endothelium was different from 
that previously reported for monocytes (5). Specifically, once 
a lymphocyte stably arrested, there was no preferential at- 
tachment of other lymphocytes just downstream from the 
first cell, but rather, attachment appeared to be random. Sec- 
ondly, P-selectin mediated a significant proportion of CD4 + 
T cell initial contact, and thus facilitated ot43rintegrin-de- 
pendent arrest, whereas E- and L-selectin were not involved 
in this system. Third, CHO-P-selectin monolayers supported 
CD4 + T  cell rolling and transient adhesion under flow at 
1.8 dynes/cm  2. That the T  cell rolling velocities were fig- 
nificantly greater on CHO-P as compared with activated HECs 
suggests that other molecule(s) in addition to P-selectin par- 
ticipate in T cell rolling on activated vascular endothelium. 
P-selectin has recently been implicated in mediating sponta- 
neous leukocyte rolling in vivo (26),  in monocyte recruit- 
ment to inflammed synovium (27), in leukocyte rolling and 
neutrophil extravasation at acute sites of inflammation (28), 
and finally, immobilized P-selectin chimera molecules sup- 
port  CD4 + T  cell  adhesion under static conditions (29). 
Fourth, surprisingly, L-selectin was not significantly involved, 
even though we (16) have reported previously that  mAb 
1183  Luscinskas  et al. blockade of L-selectin inhibited ,x,40% of unfractionated pe- 
ripheral  blood  lymphocyte adhesion  to  TNF-c~-activated 
HECs under rotating conditions. This difference may reflect 
the use of highly purified CD4 + T-cells in this study as well 
as the use of simulated blood flow conditions. Fifth, our data 
demonstrate that  ot431-VCAM-1  interactions are the pre- 
dominant mechanism that mediates T cell arrest under flow. 
Our  attempts  to  directly  show  that  the  ot4~I-VCAM-1 
pathway  mediates  T  cell  rolling  at  1.8  dynes/cm  2 using 
VCAM-l-transfected L cells were largely unsuccessful. How- 
ever, the observation that  mAb blockade of this  pathway 
significantly increased lymphocyte rolling velocities implies 
its involvement in the process of rolling.  This may reflect 
both the adhesive functions of this ligand pair and also pos- 
sible  T  cell  signalling  events mediated by o~4~1 (30,  31). 
Taken together with the inhibitory affect of P-selectin mAb, 
the data suggest that P-selectin is involved in T  cell initial 
contact and subsequent rolling on TNF-activated HECs, and 
that both P-selectin and VCAM-I-ot4B1 pathways function 
in an overlapping manner to support CD4 + rolling at very 
low velocities before stable arrest. Finally,  our findings that 
a well-characterized function blocking mAb of B2-integrins 
inhibited only 50%  of T  cell spreading/diapedesis and did 
not affect rolling or arrest suggest that a significant compo- 
nent of T cell recruitment is not dependent on ~2-integrins. 
The fact that cell-mediated immune reactions are normal in 
leukocyte adhesion deficiency type I (LAD I) patients is con- 
sistent with  this finding. 
T cell interactions with lymphoid HEV are relatively well- 
characterized (4, 21, 22).  In contrast, the mechanisms of T 
cell recruitment to peripheral sites of inflammation are not 
well understood. These studies include a detailed molecular 
analysis of CD4 § T cell recognition of endothdium and in- 
dicate a requirement for sequential and overlapping actions 
of P-selectin with Br and Bz-integrins, respectively,  during 
rolling, arrest, and diapedesis. Many immune-mediated  inflam- 
matory conditions depend on helper T ceU adhesion and trans- 
migration through cytokine-activated vascular endothelium 
at peripheral sites of antigen exposure. Therefore, our data 
suggest that blockade of ~rintegrin-VCAM-1  interactions 
and P-selectin interacting with its leukocyte ligands may have 
therapeutic benefits in autoimmune diseases and allograft re- 
jection. 
Figure 6.  Adhesion and rolling of CD4 § T ceUs on CHO P-sdectin 
monolayers under flow at 1.8 dynes/era  2. The movements of five different 
T cells on CHO P-sdectin monolayers treated with H18/7 mAb (control 
mAb) are shown. Two frames of videotape from a single experiment were 
digitized (FRAMES  I  and 2). Frame 1 (top) was then subtracted from 
Frame 2 (middle) to yield the subtracted image (bottom). In the subtracted 
image, the dark spots represent the original  position of three lymphocytes 
and the bright spots indicate their new location 1 s later. The horizontal 
arrows depict the path  of cell movement while the vertical arrowheads 
identify two cells that remained stationary. Pretreatment ofCHO P-selectin 
monolayers with blocking HPDG 2/3 totally abolished these interactions 
(not shown). Photographs were digitized from frames of videotape, the 
contrast and brightness adjusted by software (Photoshop v2.5, Adobe) and 
printed  on a digital printer (Tektronix IISDx).  Bar, 20/~m. 
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